• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations.

作者信息

Redfield M M, Nicholson W J, Edwards W D, Tajik A J

机构信息

Mayo Clinic, Rochester, Minnesota.

出版信息

Ann Intern Med. 1992 Jul 1;117(1):50-2. doi: 10.7326/0003-4819-117-1-50.

DOI:10.7326/0003-4819-117-1-50
PMID:1596047
Abstract
摘要

相似文献

1
Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations.与麦角生物碱使用相关的瓣膜疾病：超声心动图与病理学相关性
Ann Intern Med. 1992 Jul 1;117(1):50-2. doi: 10.7326/0003-4819-117-1-50.
2
From headache to heartache: ergotamine-induced aortic and mitral valvulopathy.从头痛到心痛：麦角胺诱发的主动脉瓣和二尖瓣病变。
J Am Coll Cardiol. 2013 Dec 3;62(22):2144. doi: 10.1016/j.jacc.2013.06.065. Epub 2013 Sep 22.
3
[Ergotamine-induced heart valve fibrosis and coronary microangiopathy?].[麦角胺诱发的心脏瓣膜纤维化和冠状动脉微血管病变？]
Dtsch Med Wochenschr. 1992 Nov 6;117(45):1736.
4
Development of heart valve lesions during methysergide therapy.麦角新碱治疗期间心脏瓣膜病变的发展
Br Med J. 1974 May 18;2(5915):365-6. doi: 10.1136/bmj.2.5915.365.
5
Cardiac surgery for ergotamine-induced multivalvular heart disease.麦角胺诱发的多瓣膜性心脏病的心脏手术
Thorac Cardiovasc Surg. 2013 Aug;61(5):435-7. doi: 10.1055/s-0032-1331580. Epub 2013 Mar 8.
6
Heart valve disease associated with treatment with ergot-derived dopamine agonists: a clinical and echocardiographic study of patients with Parkinson's disease.与麦角衍生的多巴胺激动剂治疗相关的心脏瓣膜病：帕金森病患者的临床和超声心动图研究
J Intern Med. 2008 Jan;263(1):90-8. doi: 10.1111/j.1365-2796.2007.01874.x. Epub 2007 Nov 23.
7
[Limb ischemia and mitral valve defect as complication of migraine medication].[肢体缺血和二尖瓣缺损作为偏头痛药物治疗的并发症]
Duodecim. 1992;108(6):558-61.
8
Ergotamine-associated valvulopathy with recurrent chylous pleural effusion.麦角胺相关瓣膜病伴复发性乳糜性胸腔积液。
Tex Heart Inst J. 2012;39(5):736-8.
9
[Clinical case of the month. Triple valvular dysfunction associated with long-term ergotamine therapy].[本月临床病例。与长期麦角胺治疗相关的三尖瓣功能障碍]
Rev Med Liege. 2003 Feb;58(2):70-2.
10
Heart abnormalities in Parkinson patients after discontinuation or continuation of ergot-derived dopamine agonists: a treatment-blinded echocardiographic study.帕金森病患者停用或继续使用麦角衍生的多巴胺激动剂后的心脏异常：一项治疗盲法超声心动图研究。
J Heart Valve Dis. 2009 Jul;18(4):463-9.

引用本文的文献

1
Cardiovascular effects and safety of classic psychedelics.经典致幻剂的心血管效应与安全性
Nat Cardiovasc Res. 2025 Feb;4(2):131-144. doi: 10.1038/s44161-025-00608-2. Epub 2025 Feb 5.
2
Approach to the Patient With Prolactinoma.催乳素瘤患者的处理方法。
J Clin Endocrinol Metab. 2023 Aug 18;108(9):2400-2423. doi: 10.1210/clinem/dgad174.
3
Mechanotransduction Mechanisms in Mitral Valve Physiology and Disease Pathogenesis.二尖瓣生理学和疾病发病机制中的机械转导机制
Front Cardiovasc Med. 2017 Dec 22;4:83. doi: 10.3389/fcvm.2017.00083. eCollection 2017.
4
Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia.卡麦角林对泌乳素瘤和特发性高泌乳素血症患者瓣膜状态影响的前瞻性长期研究。
Endocrine. 2017 Jan;55(1):239-245. doi: 10.1007/s12020-016-1120-5. Epub 2016 Oct 5.
5
Cardiac valve involvement in systemic diseases: a review.系统性疾病的心脏瓣膜受累：综述。
Clin Cardiol. 2013 Mar;36(3):117-24. doi: 10.1002/clc.22099. Epub 2013 Feb 13.
6
Ergotamine-associated valvulopathy with recurrent chylous pleural effusion.麦角胺相关瓣膜病伴复发性乳糜性胸腔积液。
Tex Heart Inst J. 2012;39(5):736-8.
7
Serotonin receptors and heart valve disease--it was meant 2B.血清素受体与心脏瓣膜病——本来应该是 2B 型。
Pharmacol Ther. 2011 Nov;132(2):146-57. doi: 10.1016/j.pharmthera.2011.03.008. Epub 2011 Apr 2.
8
Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography.血清素能通路在药物性瓣膜性心脏病中的作用及超声心动图诊断特征
J Am Soc Echocardiogr. 2009 Aug;22(8):883-9. doi: 10.1016/j.echo.2009.05.002. Epub 2009 Jun 23.
9
Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review.帕金森病中使用多巴胺激动剂与心脏瓣膜病的风险：一项系统评价
J Neural Transm (Vienna). 2009 Feb;116(2):179-91. doi: 10.1007/s00702-008-0179-4. Epub 2009 Jan 14.
10
Safety of drug therapies used for weight loss and treatment of obesity.用于减肥和肥胖症治疗的药物疗法的安全性。
Drug Saf. 2006;29(4):277-302. doi: 10.2165/00002018-200629040-00001.